stockrow
Friday 6 November 2026
Export INFU’s income statement to Excel — free account
InfuSystems Holdings, Inc.
INFU Healthcare Medical Devices
InfuSystems Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $143.4 million, up 6.36% from fiscal 2024.
- Revenue
- +2.59%
- EPS
- +33.3%
- Free cash flow
- −66.5%
- Total debt
- −22.5%
Quarter to June 2026, against a year earlier
13.73
0.17
+1.25%
Follow INFU
Alert me
InfuSystems Holdings, Inc. (INFU) P/E ratio
As of 5 November 2026, InfuSystems Holdings, Inc. (INFU) trades at a P/E ratio of 32.0×. Over the past ten years it has ranged from 0.0× (March 2023) to 5,800× (June 2023); the current reading is higher than 59% of that period. That is above the Medical Devices industry median of 25.6× and above the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 28.0× | (66.83%) |
| FY2024 | 84.5× | (68.41%) |
| FY2023 | 267× | — |
| FY2022 | 0.0× | — |
| FY2021 | 243× | 1,027.04% |
| FY2020 | 21.6× | (82.29%) |
| FY2019 | 122× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 23.0× | (5.41%) |
| Mar 2026 | 24.3× | (13.35%) |
| Dec 2025 | 28.0× | (29.65%) |
| Sep 2025 | 39.8× | 46.87% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 5,800×
Ten-year median
26.9×
Current reading's percentile
37
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RXST RxSight, Inc. compare | n/m |
| CLPT ClearPoint Neuro, Inc. compare | n/m |
| QSI Quantum-Si Incorporated compare | n/m |
| TLSI TriSalus Life Sciences, Inc. compare | n/m |
| TMCI Treace Medical Concepts, Inc. compare | n/m |
| PROF Profound Medical compare | n/m |
| LAB Standard BioTools Inc. compare | 1.8× |
| ELMD Electromed, Inc. compare | 19.4× |
| INFU InfuSystems Holdings, Inc. | 32.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)